phenoxybenzamine has been researched along with Hematologic Diseases in 2 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Hematologic Diseases: Disorders of the blood and blood forming tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| JAGANNATHAN, SN | 1 |
| SRIKANTIA, SG | 1 |
| GOPALAN, C | 1 |
| Yamazaki, H | 1 |
| Sano, T | 1 |
| Odakura, T | 1 |
| Takeuchi, K | 1 |
| Matsumura, T | 1 |
| Hosaki, S | 1 |
| Shimamoto, T | 1 |
1 trial available for phenoxybenzamine and Hematologic Diseases
| Article | Year |
|---|---|
Appearance of thrombogenic tendency induced by adrenaline and its prevention by -adrenergic blocking agent, nialamide and pyridinolcarbamate.
Topics: Administration, Oral; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; | 1971 |
1 other study available for phenoxybenzamine and Hematologic Diseases
| Article | Year |
|---|---|
Hypocholesteremic effect of phenoxybenzamine (dibenzyline), an adrenergic blocking agent. Experimental studies with monkeys and human volunteers.
Topics: Adrenergic Antagonists; Animals; Cholesterol; Haplorhini; Healthy Volunteers; Hematologic Diseases; | 1962 |